| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrombosis |
From the Department of Medicine (G.D.O.L., A.R., C.R.), University of Glasgow, Scotland; the Department of Epidemiology and Public Health (P.M.S., D.B.), University of Wales College of Medicine, UK; the Department of Epidemiology and Public Health (J.W.G.Y.), Queens University, Belfast, Ireland; and the Department of Public Health (Y.B.-S.), University of Bristol, UK.
Correspondence to Prof G.D.O. Lowe, University Department of Medicine, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, UK. E-mail gdl1j{at}clinmed.gla.ac.uk
Background There is increasing interest in the predictive value of C-reactive protein (CRP) and fibrin D-dimer in the prediction of ischemic heart disease (IHD). We assessed their joint and independent associations with IHD in a large combined analysis of 2 population cohorts.
Methods and Results Men aged 49 to 66 years from the general populations of Caerphilly and Speedwell were studied between 1982 and 1988 and re-examined for new IHD events at fixed intervals of
105 months (Caerphilly) and 75 months (Speedwell). 3213 men had CRP and D-dimer measured at baseline and 351 (11%) had a new IHD event. Mean levels of CRP and D-dimer were significantly higher among men in whom IHD developed. The relative odds of IHD in men in the top 20% of the distribution of CRP was 2.97 (95% CI, 2.04, 4.32) and for D-dimer was 2.40 (95% CI, 1.69, 3.40); CRP and D-dimer had additive effects on risk of IHD. Multivariate analysis reduced the size of the relative odds, which remained significant for D-dimer.
Conclusions Both inflammatory and thrombogenic markers are important (and potentially additive) predictors of coronary risk.
We assessed the associations of C-reactive protein and fibrin D-dimer in the prediction of ischemic heart disease in the Caerphilly and Speedwell cohorts of 3213 men aged 49 to 66 years. Both C-reactive protein and D-dimer were significantly associated with risk, indicating that inflammatory and thrombogenic markers are potentially additive predictors.
Key Words: coronary heart disease coagulation fibrin degradation products inflammation
This article has been cited by other articles:
![]() |
P.E. Morange, C. Bickel, V. Nicaud, R. Schnabel, H.J. Rupprecht, D. Peetz, K.J. Lackner, F. Cambien, S. Blankenberg, L. Tiret, et al. Haemostatic Factors and the Risk of Cardiovascular Death in Patients With Coronary Artery Disease: The AtheroGene Study Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2793 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Zieske, R. P. Tracy, C. A. McMahan, E. E. Herderick, S. Homma, G. T. Malcom, H. C. McGill Jr, J. P. Strong, and for the Pathobiological Determinants of Atheroscle Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1237 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cushman Leukocyte Count in Vascular Risk Prediction Arch Intern Med, March 14, 2005; 165(5): 487 - 488. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |